Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
08/2010
08/03/2010US7767671 3-Quinolinecarbonitrile protein kinase inhibitors
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/2010
07/29/2010WO2010085087A2 Novel cycloalkene derivatives and organic electronic devices using the same
07/29/2010WO2010083649A1 Bisarylurea derivatives and their use
07/29/2010WO2010042925A3 Compositions and methods for treating alcohol use disorders, pain and other diseases
07/29/2010US20100190799 Phenazine compounds and use thereof in autoimmune and inflammatory diseases
07/29/2010US20100190789 Piperidine/piperazine derivatives
07/29/2010US20100190764 Novel compounds
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/28/2010EP2210892A2 Neurologically-active compounds
07/28/2010EP2076494B1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/28/2010CN101790522A Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
07/28/2010CN101790521A Substituted piperazines as cb1 antagonists
07/28/2010CN101790520A Method for preparing halogenated amines
07/28/2010CN101786992A 2-hydroxymethyl-3,5,6-trimethylpyrazine derivatives, preparation methods and application thereof
07/28/2010CN101012201B Ligustrazine derivative, preparation method and medical use thereof
07/28/2010CN101007786B 2[(3-phenyl) acrylketony]-3-methylquinoxaline chemical synthesis method
07/27/2010US7763657 such as N-{-4-[3-(4-t-butylbenzyl)ureidomethyl]-2-vinylphenyl}methanesulfonamide, used as analgesics, and for treating psoriasis, pruritus, asthma, chronic obstructive pulmonary disease, urinary incontinence, inflammatory bowel disease, tinnitus and ischemia
07/27/2010US7763620 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
07/27/2010US7763618 Pyridyl derivatives and their use as therapeutic agents
07/27/2010US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors
07/27/2010CA2518435C Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation
07/27/2010CA2481241C Fused quinoxaline derivatives as inhibitors of akt activity
07/27/2010CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
07/22/2010WO2010083328A2 Methods for screening and compounds that protect against amyloid diseases
07/22/2010WO2010053572A9 Aminoalcohol lipidoids and uses thereof
07/22/2010US20100185014 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts
07/22/2010US20100184982 Detergent-dispersant, additive composition for lubricant, and lubricant composition
07/22/2010US20100184776 Piperidine/piperazine derivatives
07/22/2010US20100184765 Protein Kinase Inhibitors and Methods for Using Thereof
07/22/2010US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010US20100184730 Fatty Acid Acylated Salicylates and Their Uses
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100181527 Nitroxide containing electrode materials for secondary batteries
07/22/2010CA2749163A1 Methods for screening and compounds that protect against amyloid diseases
07/21/2010EP2208727A1 Diaryl ethers as opioid receptor antagonist
07/21/2010EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
07/21/2010EP1238977B2 Process for the preparation of a pyridinemethanol compound
07/21/2010CN1886389B Quinoxaline compounds
07/21/2010CN101781260A Nitrogen heterocyclic ring series compound and preparation method thereof
07/21/2010CN101362725B Method for preparing tetramethylpyrazine guanidine derivatives and application thereof
07/21/2010CN101143851B Ligustrazine aromatic acid ether derivatives, preparation method thereof, medicament composition and use
07/20/2010US7759345 ecteinascidins used for treating lung, colon, kidney, prostate, ovarian, breast and pancreatic cancers, leukaemia or melanoma
07/20/2010US7759339 such as 1-Phenyl-4-(m-tolylsulfonyl)piperazine, used in the treatment of type-2 diabetes, osteoporosis, hypertension, ocular disorders, cognitive disorders, the metabolic syndrome and other metabolic disorders
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2423857C Malonamide and malonamic ester derivatives with antithrombotic activity
07/20/2010CA2407866C Process for the synthesis of amine ethers from secondary amino oxides
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010CN101778832A oxopyrazine derivative and herbicide
07/14/2010CN101778831A Novel piperazine amide derivatives
07/13/2010US7754888 Insecticidal N-substituted (heteroaryl)alkyl sulfilimines
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754722 Piperazine derivatives and methods of use
07/13/2010CA2374659C N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and agents for treating neurodegenerative diseases comprising the same
07/08/2010WO2010078373A1 Substituted diketopiperazine analogs for use as drug delivery agents
07/08/2010WO2010078028A1 Modified pyrazine derivatives and uses thereof
07/08/2010WO2010078025A1 Modified pyrazine derivatives and uses thereof
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010US20100173823 Alpha2c adrenoreceptor agonists
07/08/2010US20100173777 Piperazine Compounds Having Herbicidal Action
07/08/2010DE10332560B4 Verfahren zur Herstellung von ß- Heteroaryl-2-alanin-Verbindungen über 2-Amino-2-(heteroarylmethyl)-carbonsäure-Verbindungen Process for the preparation of .beta.-heteroaryl-2-alanine compounds 2-amino-2- (heteroarylmethyl) -carboxylic acid compounds
07/08/2010CA2748490A1 Substituted diketopiperazine analogs for use as drug delivery agents
07/08/2010CA2747454A1 Modified pyrazine derivatives and uses thereof
07/08/2010CA2747402A1 Modified pyrazine derivatives and uses thereof
07/07/2010EP2203432A1 Method of treatment
07/07/2010EP1485099B1 Inhibitors of histone deacetylase
07/07/2010CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof
07/06/2010US7750156 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy) piperidine; amination; produced at a high yield and a high purity without using expensive catalysts
07/06/2010US7750155 enzyme inhibitor 2E)-3-(5-{[(3R)-1-(cyclopentylmethyl)-3-pyrrolidinyl]amino}-2-pyrazinyl)-N-hydroxyacrylamide dihydrochloride; antiinflammatory agent, antitumor agents; treating diabetes, thalassemia, fibrosis, cirrhosis, leukaemia, transplant rejections, autoimmune diseases, protozoal infections
07/06/2010US7750150 Process for producing acid adduct salt of polyacidic base compound
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010072598A1 Heterocyclic antiviral compounds
07/01/2010US20100168130 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
07/01/2010US20100168112 2-Substituted and 4-substituted aryl nitrone compounds
07/01/2010US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors
07/01/2010US20100167933 Piperazine Compounds With Herbicidal Action
07/01/2010CA2745865A1 Heterocyclic antiviral compounds
06/2010
06/30/2010EP2200613A2 Phenazine derivatives and uses thereof
06/29/2010US7745626 Stereoselective alkylation of chiral 2-methyl-4-protected piperazines
06/29/2010US7745624 salt formation; exposing the ziprasidone base in solid form to a gaseous acid in a dry environment and solvent-free; neuroleptic agent useful in the treatment of psychotic disorders, schizophrenia, and anxiety diseases
06/29/2010US7745444 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/29/2010US7745442 Methods of reducing risk of infection from pathogens
06/29/2010US7745413 Collection of traceable compounds and uses thereof
06/24/2010WO2010070615A1 Cysteine protease inhibitors
06/24/2010WO2010069819A1 Method for producing piperazinedione derivatives
06/24/2010WO2010069802A1 Heterocyclic diketone derivatives with herbicidal action
06/24/2010US20100160346 Neurologically active compounds
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160332 a2-Adrenoceptor Ligands
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160326 Pest control agent containing novel pyridyl-methanamine derivative or salt thereof
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160292 Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors
06/24/2010US20100159593 Transfection reagents
06/24/2010US20100158860 Heterocyclic antiviral compounds
06/24/2010US20100158818 Antimicrobial n-chlorinated compositions
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 187